Gadolinium MRA Contrast Side Effect Injuries

Gadolinium MRA contrast dye is used in Magnetic Resonance Imaging (MRA) so that diagnosticians can more easily differentiate between normal and abnormal tissue. Unfortunately, Gadolinium MRA contrast dye has been linked to a serious condition called Nephrogenic Systemic Fibrosis (NSF) and Nephrogenic Fribrosing Dermopathy (NSD). This serious and sometimes fatal Gadolinium side effect is seen in patients with pre-existing kidney problems. It was only recently that researchers discovered the connection between Gadolinium MRA contrast dye and NSF and NFD. In 2006 the Food and Drug Administration (FDA) issued a “Dear Healthcare Professional” letter stating that a possible link between Gadolinium MRA contrast dye and NFD and NSF exists. Then, in 2007 the FDA requested that that the manufacturers of Gadolinium MRA contrast dye update their products’ labels to include a black box warning regarding the risk of serious injury posed by Gadolinium MRA contrast dye to patients with kidney problems. The Gadolinium MRA contrast dye side effect attorneys at Parker Waichman LLP are currently evaluating Gadolinium MRA contrast dye injury cases where victims have been afflicted with NSF and NFD.